MKC1106-MT
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MKC1106-MT, covering 2010-08-03 to 2012-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma [Phase 2]